BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1460 related articles for article (PubMed ID: 16760442)

  • 1. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
    N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of Burkitt's lymphoma.
    Dave SS; Fu K; Wright GW; Lam LT; Kluin P; Boerma EJ; Greiner TC; Weisenburger DD; Rosenwald A; Ott G; Müller-Hermelink HK; Gascoyne RD; Delabie J; Rimsza LM; Braziel RM; Grogan TM; Campo E; Jaffe ES; Dave BJ; Sanger W; Bast M; Vose JM; Armitage JO; Connors JM; Smeland EB; Kvaloy S; Holte H; Fisher RI; Miller TP; Montserrat E; Wilson WH; Bahl M; Zhao H; Yang L; Powell J; Simon R; Chan WC; Staudt LM;
    N Engl J Med; 2006 Jun; 354(23):2431-42. PubMed ID: 16760443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Burkitt's and Burkitt-like lymphoma. Molecular definition and value of the World Health Organisation's diagnostic criteria].
    Stein H; Hummel M
    Pathologe; 2007 Feb; 28(1):41-5. PubMed ID: 17216514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
    Salaverria I; Siebert R
    J Clin Oncol; 2011 May; 29(14):1835-43. PubMed ID: 21482997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt's lymphoma--the message from microarrays.
    Harris NL; Horning SJ
    N Engl J Med; 2006 Jun; 354(23):2495-8. PubMed ID: 16760450
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-Barr virus and Burkitt's lymphoma.
    Magrath I; Jain V; Bhatia K
    Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of translocation t(8;14)(q24;132) in pediatric Burkitt's lymphomas using "long distance" polymerase chain reaction: a new method for diagnosis of Burkitt's lymphomas].
    zur Stadt U; Reiter A; Welte K; Sykora KW
    Klin Padiatr; 1997; 209(4):165-71. PubMed ID: 9340426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
    Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
    Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
    Lin P; Dickason TJ; Fayad LE; Lennon PA; Hu P; Garcia M; Routbort MJ; Miranda R; Wang X; Qiao W; Medeiros LJ
    Cancer; 2012 Mar; 118(6):1566-73. PubMed ID: 21882178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
    García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
    Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma.
    Salaverria I; Zettl A; Beà S; Hartmann EM; Dave SS; Wright GW; Boerma EJ; Kluin PM; Ott G; Chan WC; Weisenburger DD; Lopez-Guillermo A; Gascoyne RD; Delabie J; Rimsza LM; Braziel RM; Jaffe ES; Staudt LM; Müller-Hermelink HK; Campo E; Rosenwald A;
    Haematologica; 2008 Sep; 93(9):1327-34. PubMed ID: 18698080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis.
    Scholtysik R; Kreuz M; Klapper W; Burkhardt B; Feller AC; Hummel M; Loeffler M; Rosolowski M; Schwaenen C; Spang R; Stein H; Thorns C; Trümper L; Vater I; Wessendorf S; Zenz T; Siebert R; Küppers R;
    Haematologica; 2010 Dec; 95(12):2047-55. PubMed ID: 20823134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
    Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
    Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections.
    Haralambieva E; Kleiverda K; Mason DY; Schuuring E; Kluin PM
    J Pathol; 2002 Oct; 198(2):163-70. PubMed ID: 12237875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.